Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome

Free Subscription 23.06.2025 1 Am J Transl Res 1 Biomed Pharmacother 1 Child Abuse Negl 1 Eur J Pharmacol 1 Front Pharmacol 1 Gastro Hep Adv 1 GE Port J Gastroenterol 1 Int J Gen Med 1 Int J Med Sci 1 J Ethnopharmacol 1 J Innate Immun 1 J Transl Med 2 Neurogastroenterol Motil 1 World J Gastroenterol 1 Zhonghua Er Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Transl Res

1. GAO Y, Gong X, Qi J, Guo P, et al
   Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.
   Am J Transl Res. 2025;17:3333-3344.
   PubMed         Abstract available
   
   

   
   Biomed Pharmacother

2. BOSI A, Banfi D, Capo JD, Ponti A, et al
   Sex-dependent alteration of the enteric neuromuscular function after antibiotic-induced dysbiosis in juvenile mice and effect of Lactocaseibacillus rhamnosus GG.
   Biomed Pharmacother. 2025;189:118263.
   PubMed         Abstract available
   
   

   
   Child Abuse Negl

3. ROJAS DL, Torres-Soto NY, Martin-Estal I, de Ita JR, et al
   Impact of benevolent childhood experiences on mental and physical health in Mexican population.
   Child Abuse Negl. 2025;167:107559.
   PubMed         Abstract available
   
   

   
   Eur J Pharmacol

4. ISHIOH M, Nozu T, Miyagishi S, Funayama T, et al
   Carnosine improves colonic hyperpermeability through the brain histamine H1 receptor, basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
   Eur J Pharmacol. 2025;1002:177844.
   PubMed         Abstract available
   
   

   
   Front Pharmacol

5. LIU Q, Shi Z, Jiang Y, Zhang T, et al
   Efficacy and safety of Chinese botanical drug Si Shen Wan in irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.
   Front Pharmacol. 2025;16:1534904.
   PubMed         Abstract available
   
   

   
   Gastro Hep Adv

6. BLANKENBERGER A, Lesmana E, Yang L, Comba IY, et al
   Longitudinal Changes in the Gut Microbiome of Patients With Irritable Bowel Syndrome After Campylobacter Infection are Associated With Proteolytic Activity.
   Gastro Hep Adv. 2025;4:100683.
   PubMed        
   
   

   
   GE Port J Gastroenterol

7. FRIAS J, Martins M, Peixoto A, Macedo G, et al
   Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders.
   GE Port J Gastroenterol. 2025 Apr 21:1-15. doi: 10.1159/000545926.
   PubMed         Abstract available
   
   

   
   Int J Gen Med

8. XU X, Huang Y, Ma Z, Liu Z, et al
   Exploration of TCM Comprehensive Treatment of Irritable Bowel Syndrome Based on Pathophysiological Mechanism.
   Int J Gen Med. 2025;18:3075-3091.
   PubMed         Abstract available
   
   

   
   Int J Med Sci

9. YANG NN, Xie XX, Yan WL, Liu YD, et al
   The Autonomic Nervous System in Acupuncture for Gastrointestinal Dysmotility: From Anatomical Insights to Clinical Medicine.
   Int J Med Sci. 2025;22:2620-2636.
   PubMed         Abstract available
   
   

   
   J Ethnopharmacol

10. ZHANG L, Song Z, Huang X, Jiang B, et al
    Research progress on the regulation of interstitial cell of Cajal autophagy and apoptosis crosstalk by traditional Chinese medicine in gastrointestinal motility disorders.
    J Ethnopharmacol. 2025 Jun 11:120128. doi: 10.1016/j.jep.2025.120128.
    PubMed         Abstract available
    
    

    
    J Innate Immun

11. HAO L, Ge Y, Chen Z, Yuan D, et al
    Interaction Between Group 3 Innate Lymphoid Cells, Microbiota, and Intestinal Diseases: Mechanisms and Therapeutic Potential.
    J Innate Immun. 2025 Jun 18:1-17. doi: 10.1159/000546972.
    PubMed         Abstract available
    
    

    
    J Transl Med

12. RUSZKOWSKI J, Kachlik Z, Walaszek M, Storman D, et al
    Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review.
    J Transl Med. 2025;23:662.
    PubMed         Abstract available
    
    

    
    Neurogastroenterol Motil

13. MCKERCHAR S, Mire EL, Badcock N, Jones M, et al
    No Evidence for Unconscious Attentional Bias in People With Clinically Significant Symptoms of Functional Gastrointestinal Disorders: A Study Using the Emerging Electroencephalographic Paradigm of Fast Periodic Visual Stimulation.
    Neurogastroenterol Motil. 2025 Jun 16:e70099. doi: 10.1111/nmo.70099.
    PubMed         Abstract available
    
    
14. CUENDE-ESTEVEZ M, Hussein H, Pia F, Backaert W, et al
    Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jun 14:e70108. doi: 10.1111/nmo.70108.
    PubMed         Abstract available
    
    

    
    World J Gastroenterol

15. AL-BELTAGI M, Saeed NK, Bediwy AS, El-Sawaf Y, et al
    Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity.
    World J Gastroenterol. 2025;31:106835.
    PubMed         Abstract available
    
    

    
    Zhonghua Er Ke Za Zhi

16. WANG YF, Yao ZY, Xiao Y, Wang XQ, et al
    [A cross-sectional questionnaire survey on the prevalence and risk factors of 4 major functional gastrointestinal disorders among children in Shanghai].
    Zhonghua Er Ke Za Zhi. 2025;63:747-753.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.